BK virus: Current understanding of pathogenicity and clinical disease in transplantation

作者: Stephanie Chong , Michelle Antoni , Andrew Macdonald , Matthew Reeves , Mark Harber

DOI: 10.1002/RMV.2044

关键词:

摘要: … Interestingly, the subsequent addition of tacrolimus resulted in reversal of the sirolimus effect, with activation of BKV replication. This interaction suggests a shared pathway further …

参考文章(125)
Herman F. Wunderink, Caroline S. de Brouwer, Els van der Meijden, Diana V. Pastrana, Aloysius C.M. Kroes, Christopher B. Buck, Mariet C.W. Feltkamp, Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology Journal of Clinical Virology. ,vol. 110, pp. 22- 28 ,(2019) , 10.1016/J.JCV.2018.11.009
Neda Zareei, Hamid Reza Miri, Mohammad Hossein Karimi, Afsoon Afshari, Bita Geramizadeh, Jamshid Roozbeh, Ramin Yaghobi, None, Increasing of the interferon-γ gene expression during polyomavirus BK infection in kidney transplant patients. Microbial Pathogenesis. ,vol. 129, pp. 187- 194 ,(2019) , 10.1016/J.MICPATH.2019.02.015
S. Schaub, H. H. Hirsch, M. Dickenmann, J. Steiger, M. J. Mihatsch, H. Hopfer, M. Mayr, Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus‐Associated Nephropathy American Journal of Transplantation. ,vol. 10, pp. 2615- 2623 ,(2010) , 10.1111/J.1600-6143.2010.03310.X
H. Tedesco Silva Jr., D. Cibrik, T. Johnston, E. Lackova, K. Mange, C. Panis, R. Walker, Z. Wang, G. Zibari, Y. S. Kim, Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients. American Journal of Transplantation. ,vol. 10, pp. 1401- 1413 ,(2010) , 10.1111/J.1600-6143.2010.03129.X
H. H. Hirsch, P. Randhawa, , BK polyomavirus in solid organ transplantation. American Journal of Transplantation. ,vol. 13, pp. 179- 188 ,(2013) , 10.1111/AJT.12110
D. Petersen, J. Gossmann, H. J. Gerth, K. Dörries, T. Glück, M. Gencic, J. Löhler, A. Vallbracht, Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. American Journal of Pathology. ,vol. 143, pp. 29- 39 ,(1993)
J. A. Jackson, E. J. Kim, B. Begley, J. Cheeseman, T. Harden, S. D. Perez, S. Thomas, B. Warshaw, A. D. Kirk, Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection American Journal of Transplantation. ,vol. 11, pp. 2228- 2234 ,(2011) , 10.1111/J.1600-6143.2011.03680.X
H. H. Hirsch, F. Vincenti, S. Friman, M. Tuncer, F. Citterio, A. Wiecek, E. H. Scheuermann, M. Klinger, G. Russ, M. D. Pescovitz, H. Prestele, Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study American Journal of Transplantation. ,vol. 13, pp. 136- 145 ,(2013) , 10.1111/J.1600-6143.2012.04320.X
Adrian Egli, Sabrina Köhli, Michael Dickenmann, Hans H. Hirsch, Inhibition of Polyomavirus BK-Specific T-Cell Responses by Immunosuppressive Drugs Transplantation. ,vol. 88, pp. 1161- 1168 ,(2009) , 10.1097/TP.0B013E3181BCA422
Michelle A. Josephson, Daniel Gillen, Basit Javaid, Pradeep Kadambi, Shane Meehan, Preston Foster, Robert Harland, Richard J. Thistlethwaite, Marc Garfinkel, Walter Atwood, Joslynn Jordan, Molly Sadhu, Michael J. Millis, James Williams, Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. ,vol. 81, pp. 704- 710 ,(2006) , 10.1097/01.TP.0000181149.76113.50